Gregory Michael Christman MD

Dr. Christman joined the University of Florida faculty in 2013 to direct the Division of Reproductive Endocrinology and Infertility. He has a long-standing clinical research interest in the biology underlying the pathogenesis of uterine leiomyomas (fibroids) and for 2012-2013 he was chosen to chair the Fibroid Special Interest Group of the American Society of Reproductive Medicine.

Dr. Christman is the J Wayne Reitz Professor in the Department of Obstetrics and Gynecology and is board certified in both Obstetrics and Gynecology and the subspecialty of Reproductive Endocrinology and Infertility. His clinical interests include the care of women with the polycystic ovarian disease, premature ovarian insufficiency, endometriosis, leiomyomas, and unexplained infertility. His basic research interests include the study of apoptosis, gene therapy, and the development of prevention strategies to block the formation of uterine leiomyomas. He is currently involved in several clinical research studies in infertility management regarding the optimal use for medications used for ovulation induction, the use of GnRH analogs to prevent ovarian toxicity in women receiving alkylating chemotherapy, and the development and clinical application of novel non-hormonal treatments for endometriosis and fibroids.

Dr. Christman was one of seven principal investigators involved in the last cycle of the NICHD Reproductive Medicine Trial Network participating in the recently completed AMIGOS and PPCOS II Trials. He hopes to expand on his prior efforts to improve the care of women with endometriosis, leiomyomas, anovulation, and infertility. Dr. Christman served on the Editorial Board of Fertility and Sterility and he serves as an examiner for the American Board of Obstetrics and Gynecology. Dr. Christman received the prestigious University of Michigan League of Research Excellence Award in 2011 and is recognized as one of America’s Top Doctors in Reproductive Endocrinology and Infertility.